Literature DB >> 15140859

Serotonin syndrome due to co-administration of linezolid and venlafaxine.

Stephanie Lisa Jones, Eugene Athan, Daniel O'Brien.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15140859     DOI： 10.1093/jac/dkh257

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  7 in total

1.  Comparative evaluation of serotonin toxicity among veterans affairs patients receiving linezolid and vancomycin.

Authors:  T P Lodise; N Patel; A Rivera; L Tristani; V Lazariu; H Vandewall; L A McNutt
Journal:  Antimicrob Agents Chemother       Date:  2013-09-16       Impact factor: 5.191

2.  Linezolid and serotonin syndrome.

Authors:  Davin K Quinn; Theodore A Stern
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2009

Review 3.  Computational prediction of metabolism: sites, products, SAR, P450 enzyme dynamics, and mechanisms.

Authors:  Johannes Kirchmair; Mark J Williamson; Jonathan D Tyzack; Lu Tan; Peter J Bond; Andreas Bender; Robert C Glen
Journal:  J Chem Inf Model       Date:  2012-02-17       Impact factor: 4.956

4.  Linezolid-induced serotonin toxicity in a patient not taking monoamine oxidase inhibitors or serotonin receptor antagonists.

Authors:  Jacob Sutton; Jeff Stroup; Mo Som
Journal:  Proc (Bayl Univ Med Cent)       Date:  2016-04

5.  Linezolid-induced serotonin syndrome.

Authors:  Anish Shouan; Rajeet Kumar; Vivek Lal; Sandeep Grover
Journal:  Ind Psychiatry J       Date:  2021-03-15

6.  Linezolid is associated with serotonin syndrome in a patient receiving amitriptyline, and fentanyl: a case report and review of the literature.

Authors:  Lampros Samartzis; Paraskevi Savvari; Sofoklis Kontogiannis; Stavros Dimopoulos
Journal:  Case Rep Psychiatry       Date:  2013-03-04

7.  Pharmacokinetic drug interactions of antimicrobial drugs: a systematic review on oxazolidinones, rifamycines, macrolides, fluoroquinolones, and Beta-lactams.

Authors:  Mathieu S Bolhuis; Prashant N Panday; Arianna D Pranger; Jos G W Kosterink; Jan-Willem C Alffenaar
Journal:  Pharmaceutics       Date:  2011-11-18       Impact factor: 6.321
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.